Early-TAVR Trial 2016-07
Research payments
$4,730,937
Through program year 2019, $4,730,937 in research payments was reported against Early-TAVR Trial 2016-07, across 292 payments, paid by Edwards Lifesciences Corporation.
- Paid by
- Edwards Lifesciences Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $4,730,937 | 292 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Hemal Gada New York, NY Named on 12 payments
- Mubashir Mumtaz Camp Hill, PA Named on 12 payments
- John Gill Springfield, IL Named on 10 payments
- Philippe Genereux New York, NY Named on 10 payments
- Vijay Iyer Buffalo, NY Named on 9 payments
- Michael Fischbein Stanford, CA Named on 8 payments
- James Devries Lebanon, NH Named on 8 payments
- Joseph Desimone Lebanon, NH Named on 8 payments
- Michael Reed Missoula, MT Named on 7 payments
- James Harvey Lancaster, PA Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.